Oregon Settles With Pfizer -- Again
Oregon has agreed to settle with the pharmaceutical company, Pfizer, again over false, misleading or illegal marketing claims or promotions of its drugs.
drug prices
Can California Beat The Federal Government In Lowering Drug Prices?
California Gov. Gavin Newsom says he’s done waiting for the federal government to curtail the rising cost of prescription drugs.
Newsom has his own plan to ease that financial burden — one he hopes other states can join or replicate.
Multiple Sclerosis Patients Face Skyrocketing Drug Costs, Study Finds
Medicare patients with multiple sclerosis face skyrocketing costs for treatment due to insurance regulations that force them to pay more out of pocket for generic drugs, a study has found.
Trump Adds Global Pricing Plan To Attack On Drug Prices
Experts welcomed the administration's plan to tackle Medicare Part B's soaring drug bill but questioned its approach.
President Donald Trump’s new pledge to crack down on “the global freeloading” in prescription drugs had a sense of déjà vu.
Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices
Pharmacists have been prevented from telling consumers when the cash price for a drug is lower than the cost through their insurer. But critics say this will not affect the causes of high drug prices.
For years, most pharmacists couldn’t give customers even a clue about an easy way to save money on prescription drugs. But the restraints are coming off.
Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points
Officials are working on a multi-pronged plan to promote competition, attack the drug rebate system and introduce other ways to lower prices.
Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Briefly: Sen. Wyden blasts Trump administration over drug pricing plan
The ranking Democrat on the U.S. Senate Finance Committee and Oregon senator called on the administration to release public comments on the plan.
Oregon U.S. Sen. Ron Wyden again blasted the Trump administration on Monday over its proposed drug pricing plan.
Report: The Higher the Drug Prices, the More Industry Benefits
![[image of pills]](https://www.thelundreport.org/sites/default/files/styles/thumbnail/public/article-images/Pills%20by%20The%20Lund%20Report.jpg?itok=sGIwNztC "pills")
In the latest look at drug prices, a study released Tuesday shows that higher prices benefit key players involved in the distribution -- not the development -- of drugs. Consumers and Medicare foot the bill.
Nosse and Steiner Hayward Back Mandatory Rebates for High-Cost Drugs
The Oregon Department of Consumer and Business Services would step in if a drug exceeded $10,000 or had cost increases greater than 3.4 percent. State regulators would index a price according to what other countries have negotiated for the drugs. Consumers would also see a cap on costs that they pay out-of-pocket.
Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.
Pages
